• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

May 4, 2006

View Archived Issues

Seroconversion seen with hepatitis B vaccine in phase IIa trial

Read More

Proapoptotic activity of a novel derivative of shikonin

Read More

Phase II study of NPI-32101 completes enrollment

Read More

Xoma and Aveo sign agreement to humanize AV-299

Read More

Senesco's Factor 5A inhibits tumor development in mice

Read More

AERx iDMS phase III program set to reopen

Read More

Angiogenic factors mediate the cardioprotective properties of sildenafil citrate

Read More

GLOBE study reveals resistance and efficacy with telbivudine in hepatitis B

Read More

Studies assess ranibizumab alone and with verteporfin PTD in macular degeneration

Read More

Emisphere to receive milestone payment for use of eligen in Novartis program

Read More

Inhibitex continues Veronate review

Read More

Amicus files to begin phase I studies of AT-2101 in Gaucher's disease

Read More

BioTie grants Britannia nalmefene marketing rights for U.K. and Ireland

Read More

Enrollment completed in phase III study of Corlux in psychotic major depression

Read More

Spanish companies establish consortium, Genius Pharma

Read More

Enrollment completed in phase IIb obesity study of AOD-9604

Read More

Oral direct thrombin inhibitor MPC-0920 begins phase I study

Read More

Phase III studies of tapentadol set for Q3

Read More

Phase I trial evaluates ENMD-1198 in patients with advanced cancer

Read More

Pharmaxis completes end of phase II meeting for Bronchitol

Read More

Encouraging findings from phase I study of PV-10 in recurrent breast cancer

Read More

Phase Ib/II trial studies CTCE-9908 in patients with late-stage cancers

Read More

NDA for controlled-release zileuton targeted for Q3

Read More

TNX-355 produces durable viral-load suppression in HIV patients

Read More

E.U. approval for NovoMix 30 label extension

Read More

Dacogen approved for myelodysplastic syndromes

Read More

Novel antiinfective agents revealed in recent patents

Read More

Anti-HIV agents reported in recent patent literature

Read More

Mount Sinai researchers identify important regulator of postmenopausal bone loss

Read More

RTK inhibition reduces retinal vascular permeability in animal models of diabetic macular edema

Read More

Silencing RTP801 gene with novel siRNA shows benefit in a murine model of CNV

Read More

Snapshots of recent studies on VEGF Trap presented at the ARVO meeting

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe